Evaluating the efficacies of the hair growing stimulation and hair losing reduction products: ardermis Youth Factor extra strength Hair Formula (sh-Oligopeptide-1) and ardermis Youth Factor extra strength Hair Formula XL (sh-Oligopeptide-1)

Phase 1

Completed

• Conditions: Healthy Thai male volunteers (20-55 years old); Hair tonic, Hair growth, Hair lossing

• Registration Number: TCTR20211223006
• Lead Sponsor: Siam Bioscience Co., Ltd.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2020-12-04
• Study Start: 2021-12-23
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Male
• Target Recruitment: 98

Inclusion Criteria

1. Healthy male volunteers with baldness of the 2nd to 4th degree (Type II - IV), according to the Hamilton-Norwood classification.
2. Age between 20-55 years old.
3. No serious congenital diseases such as asthma, high blood pressure, heart disease, etc.
4. The blood pressure is not lower than 90/60 and not higher than 140/90.
5. No history of allergy to ingredients in hair care products or allergic to Minoxidil.
6. Volunteers voluntarily participate in the project after being informed of the objectives, methods and risks of the study and agree to follow the guidelines for participating in the project for a period of 6 months before starting the trial. All volunteers must sign a voluntary consent form.

Exclusion Criteria

1. Have a history of allergic reactions or abrasions on the scalp
2. During the 6 months prior to participating in the research project, the volunteer uses hair products that contain Minoxidil.
3. Get treatment for baldness with products containing 5alpha-reductase inhibitors or isotretinoin, or receiving chemotherapy or radiotherapy during the 1 year prior to participating in the research project
4. Have used natural hair care products that have contributed to hair regrowth in the past 3 months.
5. Have used steroid products on the scalp continually for a period of 14 days in the 3 months prior to participation in the study
6. Have a congenital disease such as high blood pressure or heart disease
7. History of using drug that affects blood pressure.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hair density 7 months Measuring by Leviacam,Global view of head 7 months The photographed of head area by Nikon camera

Secondary Outcome Measures

Name	Time	Method
/A N/A N/A